Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia
Clinical trial NCT01566630 · TERMINATED
Trial details
- NCT number
- NCT01566630
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-08-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.